Oncocross and JW Pharmaceutical forge new path in AI-driven drug development
In a significant stride toward revolutionizing drug discovery and development, Seoul-based biotech firm Oncocross announced on May 22nd a renewed joint research agreement with JW Pharmaceutical. This collaboration aims to leverage artificial intelligence to accelerate the development of new drugs, particularly in the fields of anticancer and regenerative medicine. Leveraging AI for Faster, More Efficient […]
